Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer
Open Access
- 1 April 1985
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 51 (4) , 573-576
- https://doi.org/10.1038/bjc.1985.80
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- INFLUENCE OF CELLULAR DNA CONTENT ON DISEASE-FREE SURVIVAL OF STAGE-II BREAST-CANCER PATIENTS1984
- Flow cytometry in clinical cancer research.1983
- Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.BMJ, 1983
- Estrogen receptor content and ploidy of human mammary carcinomaCancer, 1982
- Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.1982
- Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.1982
- Ploidy, proliferative activity and estrogen receptor content in human breast cancerCytometry, 1982
- Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptorCancer, 1981
- RELATIONSHIP OF STEROID-RECEPTOR, CELL-KINETICS, AND CLINICAL STATUS IN PATIENTS WITH BREAST-CANCER1981
- Modal Deoxyribonucleic Acid Value and Survival in Carcinoma of the BreastBMJ, 1972